BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Policy

  EnzymeWorks, Inc. Resumes Focus on Biocatalysis

  February 6, 2018

   · 

  2 min read
• Drug Development

  Sangamo Therapeutics Presents Initial Safety Data from CHAMPIONS Genome Editing Study for MPS II at WORLDSymposium

  Sangamo today announced the presentation of initial safety data from the CHAMPIONS Study, the Phase 1/2 clinical trial evaluating SB-913 for the treatment of mucopolysaccharidosis type II.

  February 6, 2018

   · 

  5 min read
• Pharm Country

  Data Presented at WORLDSymposium 2018 Show Survival to 3 Years of Age and Improvements in Liver Function in Infants with Lysosomal Acid Lipase Deficiency Treated with Kanuma (sebelipase alfa)

  Alexion today that the combined interim data from two ongoing open-label studies, VITAL and CL-08, show a 3-year survival estimate of 68% in infants with rapidly progressive lysosomal acid lipase deficiency (LAL-D) treated with Kanuma (sebelipase alfa).1

  February 6, 2018

   · 

  11 min read
• Business

  Idorsia Announces Financial Results For 2017 - Company Off to a Great Start - 4 Compounds to Enter Phase III Development

  The company announced its financial results as of December 31, 2017, which represent the business activities for the six and a half months since the demerger from Actelion on June 15, 2017.

  February 6, 2018

   · 

  11 min read
• Business

  Targovax ASA: Invitation to Fourth Quarter and Full Year 2017 Results Presentation Thursday 15 February

  The results report and the presentation will be available at www.targovax.com in the Investors section from 07:00 CET.

  February 6, 2018

   · 

  2 min read
• Genetown

  BeiGene Announces Commercial Availability of VIDAZA (Azacitidine for Injection) in China

  The drug is marketed in China by BeiGene under an exclusive license from Celgene Corporation.

  February 6, 2018

   · 

  7 min read
• ABCAM PLC Introducing FirePlex-HT High-Throughput Multiplex Immunoassays - Delivering More Data From Precious Samples

  A 2-step protocol limits hands-on time and can be easily automated, making the assay well-suited to high-throughput studies.

  February 6, 2018

   · 

  1 min read
• Bioasis to Present at the 20th Annual BIO CEO & Investor Conference

  Bioasis Technologies, Inc. announced today that it will present at the 20th Annual BIO CEO & Investor Conference, to be held February 12-13, 2018 at the New York Marriott Marquis.

  February 6, 2018

   · 

  5 min read
• Biotech Beach

  Thermo Fisher Scientific Release: Laboratory Automation Solutions Designed to Boost Productivity Showcased at SLAS 2018

  Thermo Fisher Scientific today announced new laboratory automation technologies designed to streamline workflows, optimize productivity, and speed time to results.

  February 6, 2018

   · 

  4 min read
• Biotech Beach

  Viking Announces Closing of Public Offering of Common Stock

  The gross proceeds to Viking from this offering are approximately $63.3M, before deducting underwriting discounts and commissions and other estimated offering expenses.

  February 6, 2018

   · 

  5 min read